Hi v Programs

7/30/2019 Hi v Programs

1/10

BSN4A Group 3


2/10

National HIV/STI Prevention Program

Objective:

Reduce the transmission of HIV and STI among the Most At Risk Population andGeneral Population and mitigate its impact at the individual, family, andcommunity level.

Program Activities:

With regard to the prevention and fight against stigma and discrimination, thefollowing are the strategies and interventions:

1. Availability of free voluntary HIV Counseling and Testing Service;

2. 100% Condom Use Program (CUP) especially for entertainment establishments;

3. Peer education and outreach;

4. Multi-sectoral coordination through Philippine National AIDS Council (PNAC);

5. Empowerment of communities; 6. Community assemblies and for a to reduce stigma;

7. Augmentation of resources of social Hygiene Clinics; and

8. Procured male condoms distributed as education materials during outreach.


3/10

National HIV/STI Prevention ProgramProgram Accomplishments:

As of the first quarter of 2011, the program has attained particular targets for thethree major final outputs: health policy and program development; capability

building of local government units (LGUs) and other stakeholders; and leveraging

services for priority health programs.

For the health policy and program development, the Manual of Procedures/

Standards/ Guidelines is already finalized and disseminated. The ARV Resistance

surveillance among People Living with HIV (PLHIV) on Treatment is beingimplemented through the Research Institute for Tropical Medicine (RITM).

Moreover, both the Strategic Plan 2012-2016 for Prevention of Mother to Child

Transmission and the Strategic Plan 2012-2016 for Most at Risk Young People and

HIV Prevention and Treatment are being drafted.

With regard to capability building, the Training Curriculum for HIV Counseling and

Testing is already revised. Twenty five priority LGUs provided support in

strengthening Local AIDS councils. as of March 2011, there were already 17

Treatment Hubs nationwide.

Lastly, for the leveraging services, baseline laboratory testing is being provided

while male condoms are being distributed through social Hygiene Clinics. A total of

1,250 PLHIV were provided with treatment and 4,000 STI were treated.


4/10

National HIV/STI Prevention ProgramPartner Organizations/Agencies:

The following organizations/agencies take part inachieving the goal of the National HIV/STI

Prevention Program:

Department of Interior and Local Government

(DILG)

Philippine National AIDS Council (PNAC)

Research Institute for Tropical Medicine (RITM)

STI/AIDS Cooperative Central Laboratory (SCCL)

World Health Organization (WHO)

United States Agency for International Development

(USAID)

Pinoy Plus Association

AIDS Society of the Philippines (ASP)

Positive Action Foundation Philippines, Inc. (PAFPI)

Action for Health Initiatives (ACHIEVES)

Affiliation Against AIDS in Mindanao (ALAGAD-

Mindanao)

AIDS Watch Council (AWAC)

Family Planning Organization of the Philippines

(FPOP)

Free Rehabilitation, Economic, Education, and Legal

Assistance Volunteers Association, Inc. (FREELAVA) Philippine NGO council on Population, Health, and

Welfare, Inc. (PNGOC)

Leyte Family Development Organization (LEFADO)

Remedios AIDS Foundation (RAF)

Social Development Research Institute (SDRI)

TLF share Collectives, Inc. Trade Union Congress of the Philippines (TUCP)

Katipunang Manggagawang Pilipino

Health Action Information Network (HAIN)

Hope Volunteers Foundation, Inc.

KANLUNGAN Center Foundation, Inc. (KCFI)

Kabataang Gabay sa Positibong Pamumuhay, Inc.(KGPP)

Program Manager:

Dr. Jose Gerard B. Belimac

Department of Health-National Center for Disease

Prevention and Control


5/10

Antiretroviral Treatment as

Prevention (TASP) of HIVHIV causes an infectious disease that, with the right prevention

interventions delivered within a human rights framework, can be controlled and

possibly even eliminated. WHO, UNAIDS and 19 the United Nations General

Assembly have called for 15 million people to be on ART by 2015. ART has

considerable benefit, both as treatment and in preventing HIV and TB. It is certain

that TasP needs to be considered as a key element of combination HIV preventionand as a major part of the solution to ending the HIV epidemic. In the short and

medium term, while countries are concentrating their efforts on scaling up

treatment according to the eligibility criteria recommended by WHO, it is expected

that they will concurrently identify opportunities to maximize the use of ART for

prevention purposes (TasP). The focus will be on specific populations in whom the

prevention impact is expected to be greatest (e.g. serodiscordant couples,pregnant women, key populations). During 2012, WHO is issuing updates and

guidance for these populations, and is working with countries to address

programmatic and operational challenges to inform the consolidated guidelines to

be released in mid-2013.


6/10


Prevention (TASP) of HIVWHO Priority Areas of Work

WHO will work in three priority areas, in close collaboration with Member States,

implementing partners, UNAIDS and other UN cosponsors, civil society and

researchers:

Priority area of work 1. Develop norms and standards for the strategic use of ARVs

(including TasP).

Priority area of work 2. Inform programmatic and operational decisions.

Priority area of work 3. Define metrics for monitoring/evaluating TasP impact.


7/10


Prevention (TASP) of HIVPriority area of work 1: develop norms and standards for treatment as prevention

WHOs first priority is to continue to support the implementation of its current guidelines and recommendations,which are likely to provide considerable preventive and clinical benefits for HIV and TB for the individual and

community. Over the past few years, WHO has been conceptualizing the use of ART to explicitly consider ways by

which both the individual and public health preventive benefits of ART can be maximized. WHO recognizes the need to

provide timely, state-of-the-art guidance on the use of ARVs for both HIV treatment and prevention, including TasP. It

also recognizes that programs are in various stages of expanding access to ART to achieve universal access goals, and

will need to prioritize their interventions. WHO will expand the public health approach to include programmatic and

operational guidance, specifically on the service delivery aspects of linking HIV testing approaches to care and

treatment as well as prevention. The first guidance that explicitly addresses TasP is the 2012 couples HIV testing and

counseling guidelines. WHO has embarked on formulating critical questions for TasP, which will be answered partly by

systematic reviews and the standard WHO GRADE review of the evidence, including data from modeling as well as

ongoing demonstration projects and implementation research. WHO will address both individual- and

community/population-level benefits of earlier initiation of treatment.

At present, the key questions being addressed for the development of WHO TasP recommendations for the 2013 guidelines

are as follows:

What is the impact of earlier initiation of ART on morbidity and mortality? What is the impact

of earlier initiation of ART on TB incidence and mortality?

What is the impact of earlier initiation of ART on behavioural outcomes?

What is the prevention benefit of starting ART earlier for people living with HIV within key

populations?

What is the impact of earlier initiation of ART on ARV toxicity?

What is the impact of earlier initiation of ART on transmitted drug resistance to HIV?


8/10


Prevention (TASP) of HIVPriority area of work 2: inform programmatic and operational decisions

WHO is working on a number of programmatic and operational areas, including programmatic guidance and ethicsconsultations focused on the strategic use of ARVs, and operational guidance as part of Treatment 2.0, which will inform

scale-up models. WHO is also supporting implementation research efforts in Asia and Africa.

Key questions for decision-makers include the following:

1. What is the magnitude of the prevention benefit of ART in the local epidemiological context? What will the impact of ART be

on TB morbidity, mortality and transmission? (Annual national TB programme case notification rates can provide good

proxy for ART impact.)2. How can the results of research and programme data be translated into effective programmes implemented at scale and at

what additional cost?

3. In which settings and populations should ART be initiated early to have the greatest overall impact on the HIV and TB

epidemic curve? 18 Programmatic update June 2012

4. What is the appropriate mix of prevention interventions to optimize this impact?

5. What are the best (most effective and efficient) ways to deliver ART and how can optimal

retention in treatment be achieved?

This highlights the principles of knowing your epidemic and response, and the potential role of mathematical modeling to inform

program implementation. Strengthening existing systems for surveillance and response monitoring remains critical, and

implementation research is increasingly being recognized as an important tool for decision-makers. Key components of

implementation sciences are related to measurement, operational research and impact evaluation, and can include

estimation of cost and costbenefit. The experience from early program implementation, demonstration projects and

observational/cohort studies will provide valuable information for formulating critical programmatic questions and helparrive at policy decisions based on the modeled impact and costbenefit of ART for prevention interventions, including HIV

drug resistance.


9/10


10/10

HIV-AIDS campaign evolving to target

youthIn what seems to be a timely response to the recent trend of more HIV cases involving young people, the

Philippine Catholic HIV and AIDS Network (PhilCHAN) launches an HIV-AIDS campaign targeting the youth.

The HIV campaign is shaping into a youth campaign, Josephine Ignacio, the HIV and AIDS Program

Coordinator of NASSA (National Secretariat for Social Action) said in an interview.

The groups youth-directed 0% FEAR | 100% LOVEcampaign aims to encourage young people to talk about the

reality of HIV-AIDS with peers and family members, specifically to eliminate the stigma and rejection associated with

those affected by the virus. PhilCHAN, which has around 44 member-organizations, is currently working on visualmaterials like posters that will appeal to the 15-24 year old age bracket, the youth segment that accounted for 27%

of HIV cases as of June 2012. The suggestion to come out with materials that speak the language of young people

came from the Episcopal Commission on Youth (ECY), one of the newest members of the network. ECY, Pro-Life

Philippines and the Catholic Educational Association of the Philippines (CEAP), all members of PhilCHAN, are working

on the visual materials that will be similar to the I got tested because I love you posters that targeted married

people and couples preparing to get married. Ignacio recalled how effective the previous campaign was with a good

number of people contacting the network to know more about HIV-AIDS because they saw the posters in LRT

stations or in their parishes.

What the Church is saying is: Speak up! Talk about the virus because even the members of your family, your circle of

friends are not safe from it. The virus spreads as we keep silent about it, Ignacio, who was part of the core group

that started PhilCHAN in 2009, explained. Regional coordinator of Southeast Asia HIV and AIDS Catholic Network Fr.

Dan Cancino also said during a recent HIV-AIDS training for the clergy and members of the religious, getting rid of the

stigma of talking about sex and HIV-AIDS is crucial to the campaign. Recent statistics from the National Epidemiology

Center of the Department of Health estimates there are 9 new HIV cases everyday in the country.Out of those 9cases 2.4 will involve young people.

Documents

Hi v Programs